Luca Mastrantoni

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Luca Mastrantoni

Mar 28, 2025, 16:06 | Insight

Armando Orlandi: Our new study on HER2-low luminal BC is Riding Breast Cancer's Biggest Data's Wave

Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post…

Feb 8, 2025, 06:45 | Science

Armando Orlandi: A new ML model predicts chemo response in HR+/HER2- breast cancer with 81% accuracy

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared his recent article on X…

Dec 5, 2024, 09:32 | Blog

Comparison of 1st chemotherapy in unresectable locally advanced or metastatic PDAC

Arndt Vogel shared on X: "Comparison of 1st chemotherapy in unresectable locally advanced or metastatic PDAC…

Oct 14, 2024, 13:56 | Insight

Katsuaki Maehara: Comprehensive Genome Profiling using NGS

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X: “Comprehensive Genome Profiling…

All: 4 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023